Hemostatic abnormalities associated with VIH infection;Alteraciones de la coagulación en la infección por VIH

Revista de Investigacion Clinica

Volumn 49, Issue 1, 1997, Pages 51-66

  Majluf Cruz, Abraham ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AIDS; Hemostatic abnormalities; Human immunodeficiency virus; Thrombocytopenia

Indexed keywords

BLOOD CLOTTING DISORDER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; REVIEW;

BLOOD COAGULATION DISORDERS; HIV INFECTIONS; HUMANS;

EID: 3242870357     PISSN: 00348376     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (165)

1. Morris L, Distenfeld A, Amorosi E, Karpatkin S. Autoimmune thrombocytopenic purpura in homosexual men. Ann Intern Med 1982; 96:714-7.
2. Mir N, Costello C, Luckit J, Lindley R. HIV- disease and bone marrow changes: a study of 60 cases. Eur J Haematol 1989; 42:339-43.
3. Goldman R, Lang W, Lyman D. Acute AIDS viral infection. Am J Med 1986; 81:1122-3.
4. Ribera E, Ocana I. Almirante B, Gomez J, Monreal P, Martinez-Vazquez JM. Autoimmune neutropenia and thrombocytopenia associated with development of antibodies to human immunodeficiency virus. J Infect 1989; 18:167-70.
5. Landonio G, Nosari A, Spinelli F. HIV-related thrombocytopenia. N Engl J Med 1993; 328:1785.
6. Zon LI, Groopman JE. Hematologic manifestations of the human immunodeficiency virus (HIV). Semin Hematol 1988; 25:208-18
7. Bierling P, Bettaieb A, Oksenhendler E. Human immunodeficiency virus-related immune thrombocytopenia. Semin Thromb Hemost 1995; 21:68-75.
8. Schlech W, Nesdoly C, Meagher N. The epidemiology of immune thrombocytopenia (ITP): are increase in ITP in the population a manifestation of HIV epidemic? V International Conference on AIDS 1989; 135.
9. Ratnoff OD, Menitove JE, Aster RH, Lederman MM. Coincident classic hemophilia and "idiopathic" thrombocytopenic purpura in patient under concentrates of hemophilic factor (factor VIII). N Engl J Med 1983; 308:439-42.
10. Savona S, Nardi MA, Lennette ET, Karpatkin S. Thrombocytopenic purpura in narcotics addicts, Ann Intern Med 1985; 102:737-41.
11. Ellaurie M, Burns ER, Bernstein LJ, Shah K, Rubinstein A. Thrombocytopenia and human immunodeficiency virus in children, Pediatrics 1988; 82:905-8.
12. Oksenhendler E, Bierling P, Parcet J-P, Rabian P, Seligmann M, Clauvel JP. Response to therapy in 37 patients with HIV-related thrombocytopenic purpura. Br J Haematol 1987; 66:491-5.
13. Karpatkin S, Nardi MA, Hymes B. Immunologic thrombocytopenic purpura after heterosexual transmission of human immunodeficiency virus (HIV). Ann Intern Med 1988; 109:190-3.
14. Rossi G, Goria R, Stellini R, Franceschini F, Bettinzioli M, Cadeo G, et al. Prevalence, clinical, and laboratory features of thrombocytopenia in HIV-infected individuals. AIDS Res Hum Retro 1990; 6:261-9.
15. Karpatkin S. Immunologic thrombocytopenic purpura in HIV-seropositive homosexuals, narcotic addicts and hemophiliacs. Semin Hematol 1988; 25:219-29.
16. Murphy MF, Metcalfe P, Walters AH, Carne CA, Weller IVD, Linch DC, et al. Incidence and mechanism of neutropenia and thrombocytopenia in patients with human immunodeficiency virus infection. Br J Haematol 1987; 66:337-40.
17. Abrams DI, Lewis BJ, Beckstead JH, Casavant CA, Drew L Persistent diffuse lymphadenopathy in homosexual men: endpoint or prodrome? Ann Intern Med 1984; 100:801-8.
18. Rousselect MC, Audouin J, Le Tourneaou A, Bouchard I, Espinoza P, Kazatchkine M. et al. Idiophathic thrombocytopenic purpura in patients at risk for acquired immunodeficiency syndrome. Arch Pathol Lab Med 1988; 112:1242-50.
19. Abrams DI, Chinn EK, Lewis BJ, Volberding Pa, Conant MA, Townsend Rm. Hematologic manifestations in homosexual men with Kaposi's sarcoma. Am J Clin Pathol 1984; 81:13-8.
20. Delacretaz F, Perey L, Schmidt PM, Chave JP, Costa J. Histopathology of bone marrow in human immunodeficiency virus infection. Virchows Arch A Pathol Anat Histopathol 1987; 411:543-51.
21. Shenoy CM, Lin JH. Bone marrow findings in acquired immunodeficiency syndrome (AIDS). Am J Med Sci 1986; 292:372-5.
22. Treacy M, Lai L, Costello C, Clark A. Peripheral blood and bone marrow abnormalities in patients with HIV-related disease. Br J Haematol 1987; 65:289-94.
23. Walsh C, Krigel R, Lennette E, Karpatkin S. Thrombocytopenia in homosexual patients: prognosis, response to therapy and prevalence of antibody to the retrovirus associated with the acquired immunodeficiency syndrome. Ann Intern Med 1985; 103:542-5.
24. Eyster ME, Rabkin CS, Hilgartner MW, Aledort LM, Ragni MV, Sprandio J, et al. Human immunodeficiency virus-related conditions in children and adults with hemophilia: rates, relationship to CD4 counts and predictive value. Blood 1993; 81:828-34.
25. Couderc LJ, Clauvel JP, Ballet JJ. Clinical and biological parameters in patients with presistent generalizaed lymphadenopathy. II International Conference on AIDS 1986; 43.
26. Shannon KM, Amman AJ. Acquired immunodeficiency syndrome in childhood. J. Pediatrics 1985; 106:332-42.
27. Mientjes GCH, Van Ameijden EJC, Mulder JW, Van den Hoek JAR, Coutinho RA, Von dem Borne RT. Prevalence of thrombocytopenia in HIV-infected and non-HIV infected drug users and homosexual men. Br J Haematol 1992; 82:615-9.
28. Oksenhendler E, Archambault MP, Delfraissy JF. HIV-related immune thrombocytopenia: follow-up and treatment of 132 patients. V International Conference on AIDS 1989; 101.
29. Goedert JJ, Biggar RJ, Weiss SH, Eyster ME, Melbye M, Wilson S, et al. Three year incidence of AIDS in five cohorts of HTLV-III-infected risk group members. Science 1986; 231:992-5.
30. Holzman RS, Walsh CM, Karpatkin S. Risk for the acquired immunodeficiency syndrome among thrombocytopenic and nont-hrombocytopenic homosexual men seropositive for the human immunodeficiency virus. Ann Intern Med 1987; 106:383-6.
31. Zucker-Franklin D. The effect of viral infections on platelets and megakaryocytes. Semin Hematol 1994; 31:329-37.
32. Ballem PJ, Belzberg A, Devine D, Doubroff P, Mikulash C, Spurston B, et al. Pathophisiology of thrombocytopenia associated with HIV infection in homosexal men. Blut 1989; 59:111-4.
33. Oksenhendler E, Bierling P, Ferchal F, Clauvel JP, Seligmann M. Zidovudine for thrombocytopenic purpura related to human immunodeficiency virus (HIV) infection. Ann Intern Med 1989; 110:365-8.
34. Zucker-Franklin D, Cao Y. Megakaryocytes of human immunodeficiency virus-infected individuals express viral RNA. Proc Natl Acad Sci USA 1989; 86:5595-9
35. Zucker-Franklin D, Termin CS, Cooper MC. Structural changes in the megakaryocytes of patients infected with the human immune deficiency virus (HIV-1) Am J Pathol 1989; 134:1295-303.
36. Laurian Y, Le Bras P, Ellrodt A, Alvin P. Immune thrombocytopenia gammaglobulin and seropositivity to the human T-lymphotropic virus type III. Ann Intern Med 1986; 105:145-6.
37. Bender BS, Bohnsack JF, Sourlis SH, Frank MM, Quinn TC. Demonstration of defective C3-receptor-mediated clearence by the reticuloendothelial systhen in patients with the acquired immunodeficiency syndrome. J Clin Invest 1987; 79:715-20.
38. Bender BS, Quinn TC, Spivak JL. Homosexual men with thrombocytopenia have impaired reticuloendothelial system Fc receptor-specific clearence. Blood 1987;70:392-5.
39. Stutte HJ, Muller H, Falk S, Schmidts HL. Pathophysiological mechanisms of HIV-induced defects in haemopoiesis: pathology of the bone marrow. Res Virol 1990; 141: 195-200.
40. Costello C. Haematological abnormalities in human immunodeficiency virus (HIV) disease. J Clin Pathol 1988; 41:711-5.
41. Sakaguchi M, Sato T, Croopman JE. Human immunodeficiency virus infection of megakaryocytic cells. Blood 1991; 77:481-5.
42. Louache F, Henri A, Bettaieb A, Eksenhendler E, Raguin C, Tulliez M, et al. Role of human immunodeficiency virus replication in defective in vitro growth of hematopoietic progenitors. Blood 1992; 80:2991-9.
43. Ganser A. Abnormalities of hemopoiesis in acquired immunodeficiency syndrome. Blut 1988; 56:49-54.
44. Monte D, Groux H, Raharivino B, Plouvier B, Dewulf J, Clavel T, et al. Productive human immunodeficiency virus-1 infection of megakaryocytic cells is enhanced by tumor necrosis factors-α. Blood 1992; 79:2670-9.
45. Zauli G, Re MC, Davies BR, Sen L, Visani Gugliotta L, et al. Impaired in vitro growth of purified (CD34+) hematopoietic progrenitors in human immunodeficiency virus-1 seropositive thrombocytopenic individuals. Blood 1992; 79:2680-7.
46. Wickramasinghe SN, Beatty C, Shiels S. Tomlinson DR. Harris JR. Ultrastructure of bone marrow in HIV infection: evidence of dyshaemopoiesis and stromal cell damage. Clin Lab Haematol 1992; 14:213-29.
47. Moses AV, Williams S, Heneveld ML. Strussenberg J, Rarick M, Loveless M, et al. Human immunodeficiency virus infection of bone marrow endothelium reduce induction of stromal hematopoietic growth factors. Blood 1996; 87:919-25.
48. Suda T, Suda J, Kajigaya S, Nagata S, Asano S, Saito M, et al. Effects of recombinant murine granulocyte colony-stimulating factors on granulocyte-macrophage and blast colony formation. Exp Hematol 1987; 15:958-65.
49. Ikebuchi K, Wong GG, Clarck SC, Ihle JN, Hirari H. Ogawa M. Interleukin 6 enhancement of interleukin 3-dependent proliferation of multipotential hemopoietic progenitors. Proc Natl Acad Sci USA 1987; 84:9035-9.
50. Bel-Ali Z, Dufour V, Najean Y. Platelet kinetics in human immunodeficiency virus induced thrombocytopenia. Am J Hematol 1987; 26:299-304.
51. Clark WF, Tevaarwerk GJM, Rei BD. Human platelet-immune complex interaction in plasma. J Lab Clin Med 1982; 100:917-31.
52. Beardsley DS, Spiegel JE, Jacobs MM, Handin RI, Lux SE. Platelet membrane glycoprotein IIIa contains target antigens that binds antiplatelet antibodies in immune thrombocytopenias. J Clin Invest 1984; 74:1701-7.
53. Miescher P, Straessle R, Experimentelle studien uber den Mechanismus der Thrombocyten-Schadigung durch Antigen-Antikorper-Reaktionen. Vox Sang 1956; 1:83-94.
54. Bettaieb A, Oksenhendler E, Fromont P, Duedari N, Bierling P. Immunochemical analysis of platelet autoantibodies in HIV-related thrombocytopenic purpura: a study of 68 patients Br. J Haematol 1989; 73:241-7.
55. Borradori L, Castelli D, Flueckiger E, Nydegger UE. Clinical significance of platelet associated immunoglobulins in narcotic addicts with human immunodeficiency virus infection. Clin Immunol Immunopathol 1990; 54:256-65.
56. Klaasen RJL, van der Lelie J, Vlekke ABJ, Weigel HM, Beftinck-Schattenkerk JK, Reiss P, et al. The serology and immunochemistry of HIV-induced platelet boun immunoglobulin. Blut 1989; 59:75-81.
57. Hackett T. Kelton JC, Powers P. Drug-induced platelet destruction. Semin Thromb Hemost 1982; 8:116-37.
58. McMillan R. Chronic idiopathic thrombocytopenic purpura. N Engl J Med 1981; 304:1135-47.
59. Ballem PJ, Segal CM, Stratton JR, Gernsheimer T, Adamson JW, Slichter SJ, Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura: evidence of both impaired platelet production and increased platelet clearance. J Clin Invest 1987; 80:33-40.
60. Kouri YH, Basch RS, Karpatkin S. B-cell subsets and platelet counts in HIV-1 seropositive subjects. Lancet 1992; 339:1445-6.
61. Walsh CM, Nardi NA, Karpatkin S. On the mechanisms of thrombocytopenic purpura sexually active homosexual men. N Engl J MEd 1984; 311:635-9.
62. 2 antibodies in thrombocytopenic patients at risk for acquired immunodeficiency syndrome. J Clin Invest 1986; 77:1756-61.
63. Taaning E, Schiebel E, Larsen B, Ingerslev J. Pattern of immunoglobulin classes and IgG subclasses of platelet associated immunoglobulin in HIV seropositive hemophiliacs. Vox Sang 1988; 54:205-9.
64. Karpatkin S, Nardi MA. Immunologic thrombocytopenic purpura in human immunodeficiency virus-seropositive patients with hemophilia. J Lab Clin Med 1988; 111:441-8.
65. Karpatkin S. Nardi M, Lennette ET, Byrne B, Poiesz B. Anti-human immunodeficiency virus type I antibody complexes on platelets of seropositive thrombocytopenic homosexuals and narcotic addicts. Proc Natl Acad Sec USA 1988; 85:9763-7.
66. Bettaieb A, Fromont P, Louache F, Oksenhendler E, Vainchenker W, Duedari N, et al. Presence of cross-reactive antibody between human immunodeficiency virus (HIV) and platelet glucoproteins in HIV-related immune thrombocytopenic purpura. Blood 1992; 80:162-9.
67. Van der Lelie J, Lange JMA, Vos JJE, van Dalen CM, Danner SA, von dem Borne AE. Autoimmunity against blood cells in human immunodeficiency virus (HIV) infection. Br J Haematol 1987; 67:109-14.
68. Stricker RB. Hemostatic abnormalities in HIV disease. Hematol Oncol Clin North Am 1991; 5:249-65.
69. Ballem PJ. HIV-associated thrombocytopenia. Educational Program. American Society of Hematology 1993; 75-7.
70. McMillan R, Tani P, Millard F, Berchtold P, Renshaw L, Woods VL Platelet-associated and platelet anti-glycoprotein autoantibodies in chronic ITP. Blood 1987; 70:1040-5.
71. Stricker RB, Abrams DI, Corash L, Shuman MA. Target platelet antigen in homosexual men with immune thrombocytopenia. N Engl J Med 1985; 313:1375-80.
72. 2 antibodies in rheumatoid arthritis. Arthritis Rheun 1983; 26:1481-92.
73. 2 antibodies in rheumatoid arthritis and systemic lupus erythematous. Arthritis Rheum 1982; 25:1298-306.
74. 2 portion of IgG. Clin Exper Immunol 1980; 42:378-86.
75. 2 antibodies and possible immunologic control mechanisms in systemic lupus erythematous. Arthritis Rheum 1984; 27;1387-96.
76. Karpatkin S, Nardi MA, Kouri YH. Internal-image anti-idiotype HIV-1 gp120 antibody in human immunodeficiency virus 1 (HIV-1)-seropositive individuals with thrombocytopenia. Proc Natl Acad Sci USA 1992; 89:1487-91.
77. Stanworth Dr, Solder B, Lewin IV, Nayyar S, Marschang P, Wachter H, et al. Related epitopes in HIV viral coat proteins and human IgG. Lancet 1989; 1:1458-9.
78. Susal C, Lewin IV, Stanworth DR, Terness P, Daniel V, Oberg HH, et al. Anti-IgG autoantibodies in HIV-infected hemophilia patients. Vox Sang 1992; 62:224-9
79. Karpatkin S. HIV-1-related thrombocytopenia. Hematol Oncol Clin North Am 1990; 4:193-218.
80. Abrams DI, Kiprov DD, Gedert JI, Sarngadharan MG, Gallo RC, Volberdig PA. Antibodies to human T-lymphotrophic virus type III and the development of the acquired immunodeficiency syndrome in homosexual men presenting with immune thrombocytopenia. Ann Intern Med 1986; 104:47-50.
81. Brusamolino E, Malfitano A, Pagnucco C, Sacchi P, Orlandi E, Domini G, et al. HIV-related thrombocytopenic purpura: a study of 24 cases. Hematologica 1989; 74:51-6.
82. Landonio G, Galli M, Nosari A, Lazzarin A, Cipriani D, Crocchiolo P, es al. HIV-related severe thrombocytopenia in intravenous drug abusers: prevalence, response to therapy in a medium-term follow-up, and pathogenic evaluation. AIDS 1990; 4:29-34.
83. Goldsmith JC, Krisker CT. Successful conservative management of thrombocytopenia in adult hemophiliacs. Transfusion 1988; 28:68-9.
84. Goldsweig HG, Grossman R, William D. Thrombocytopenia in homosexual men. Am J Hematol 1986; 21:243-7.
85. Beard J, Savidge GF. High-dose intravenous immunoglobulin and splenectomy for the treatment of HIV-related immune thrombocytopenia in patients with severe hemophilia. Br J Haematol 1988; 68:303-6.
86. Finch CA, Bellotti B, Stray S, Lipschitz DA, Cook JD, Pippard MP. et al. Plasma ferritin determination as a diagnostic tool. West J Med 1986; 145:657-63.
87. Perkocha LA, Rodgers GM. Hematological aspects of human immunodeficiency virus infection: laboratory and clinical considerations. Am J Hematol 1988; 29:-105.
88. Bussel JB, Haimi JS. Isolated throbocytopenia in patients infectec with HIV: treatment with intravenous gammaglobulin. Am J Hematol 1988; 28:79-84.
89. Hymes KB, Green JB, Karpatkin S. The effect of azidothymidine on HIV-related thrombocytopenia. N Engl J Med 1988; 318:516-7.
90. Pena JM, Arnalich F, Barbado FJ, Dominguez A, Mostaza J, Valencia ME, et al: Successful zidovudine therapy for HIV-related severe thrombocytopenia. Acta Hematol 1990; 83:86-8.
91. Ratner L. Human immunodeficiency virus-associated autoimmune thrombocytopenic purpura: a review. Am J Med 1989; 86:194-8.
92. Gottlieb MS, Wolfe PW, Chafety S. Case report: response to AIDS-related thrombocytopenia to intravenous and oral azidothymidine (3′-azido-3′-deoxythymidine). AIDS Res Hum Retrov 1987;3:109.
93. Neil BJ, Johnson GJ, Pomeroy C. Zidovudine therapy for severe human immunodeficiency virus-related thrombocytopenia. Am J Med 1989; 85:744-5.
94. Pechere M, Sammi K, Hirschel B. HIV-related thromocytopenia. N Engl J Med 1993; 328:1785-6.
95. Ballem P, Belzberg A, Chambers H, Spruston B. Platelet production in HIV infection. Evidence for a compensated thrombolytic state enhanced by AZT. V International Conference on AIDS 1989; 93.
96. Ballem PJ, Belzerg A, Devine DV, Lyster D, Spruston B, Chambers H, et al. Kinetic studies of the mechanism of thrombocytopenia in patientes with human immunodeficiency virus infection. N Engl J Med 1992; 327:1779-84.
97. Potagge JC, Benson CA, Spear JB, Landay AL, Kessler HA. Treatment of human immunodeficiency virus related thrombocytopenia with zidovudine. JAMA 1988; 260:3045-8.
98. The Swiss Group for Clinical Studies on the Acquired Immunodeficiency Syndrome. Zidovudine for the treatment of thrombocytopenia associated with human immunodeficiency virus (HIV): a prospective study. Ann Intern Med 1989; 109:718-21.
99. Cinque P, Landonio G, Lazzarina A, Nosari AM, Ruggieri A, Coen M, et al. Long-tern treatmen with zidovudine in patientes with human immunodeficiency virus (HIV)-associated thrombocytopenia: modes of response and correlation with markers of HIV replication. Eur J Haematol 1993; 50:17-21.
100. Landonio G, Cinque P, Nosari A, Gafa S, Rizzo F, Coen M. et al. Comparison of two dose regimens of zidovudine in an open, randomized, multicentre study for HIV-related thrombocytopenia. AIDS 1993; 7:209-12.
101. Durand JM, Lefebre P, Hovette P, Issifi S, Mongin M. Dapsone for thrombocytopenic purpura related to human immunodeficency virus infection. Am J Med 1991;90:29-32.
102. Pollak AN, Janinis J, Green D. Successful intravenous immune globulin therapy for human immunodeficiency virus-associated infection. Arch Intern Med 1988; 148:695-7.
103. Osborne BM, Guarda LA, Butler JJ. Bone marrow biopsies in patients with the acquired immunodeficiency syndrome. Human Pathol 1984; 15:1048.53.
104. Kellner SV, McGrath KM, Street AM. Management of human immunodeficiency virus-induced thrombocytopenia in hemophilia. Aust NZ J Med 1987; 17:581-4.
105. Panzer S, Zeitelhuber U, Hach V, Brackmann HH, Niesser H, Muller-Eckhardt C. Immune thrombocytopenia in severe hemophilia A treated with high-dose intravenous immunoglobulin. Transfusion 1986; 26:69-72.
106. Oksenhendler F, Bierling P, Brassard Y, Schenhetzler C, Girard PM, Selingman M, Clauvel JP. Anti-Rh immunoglobulin therapy for human immunodeficiency virus-related thrombocytopenic purpura. Blood 1988; 71:1499-502.
107. Mintzer DM, Real FX, Jovino L, Known SE. Treatment of Kaposi's sarcoma and thrombocytopenia with vincristine in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1985; 102:200-2.
108. Metroka CE, Moore A, Sonnabend JA, Cunningham-Rundles S. Risks with danazol in the acquired immunodeficiency syndrome. Ann Intern Med 1984; 101:564-65.
109. Rosenfelt FP, Rosembloom BE, Weinstein IM. Immune thrombocytopenia in homosexual men. Ann Intern Med 1986; 104:583.
110. Shafer RW, Offit K, Macris NT, Horbar GM, Ancona L, Hoffman IR. Possible risk of steroid administration in patients at risk of AIDS. Lanced 1985; 1:934-5.
111. Costello C, Treacy M, Lai LK. Treatment of immune thrombocytopenic purpura in homosexual men. Scand J Haematol 1986; 36:507-10.
112. Northfelt DW, Mitzuyasu RT. Hematologic complications of HIV infection. En: DeVita VT, Hellman S, Rosenberg SA, Curran J, Essex M, Fauci AS, editors. AIDS: etiology, diagnosis, treatment, and prevention. Philadelphia: JB Lippincott, 1992:337-45.
113. Gill PS, Loureiro C, Berstein-Singer M, Rarick MU, Sattler F, Levine AM. Clinical effects of glucocorticoids on Kaposi's sarcoma related to the acquired immunodeficiency syndrome (AIDS). An Intern Med 1989; 110:937.
114. Schneider PA, Abrams DI, Rayner AA, Hohn DC. Immunodeficiency associated thrombocytopenic purpura (IDTP): response to splenectomy. Arch Surg 1987; 122:1175-8.
115. Gabarre J, Azar N, Ben Othman T, Gharakhanian S, De Sahb R, Dohin E, et al. Effects a long terme de la splenectomie pour purpura thrombopeique immunologique lie au virus d l'immunodeficience humaine. Presse Medicale 1991;20:2239-45.
116. Landonio G, Nosari AM, Barbarano L, Muti G, Panzacchi G, Baudo F, et al Splenectomy for severe HIV-related thrombocytopenia in heroin abusers. Br J Haematol 1988; 69:290.
117. Kim HC, Raska K, Trooskin S, Saidi P. Immune thrombocytopenia in hemophiliacs infected with the human immunodeficiency virus and their response to splenectomy. Ann Intern Med 1989; 149:1685-8.
118. Mathew A, Raviglione MC, Niranjan U, Sabatini MT, Distenfeld A. Splenectomy in patients with AIDS. Am J Hematol 1989; 32:184-9.
119. Ellis ME, Neal KR, Leen CLS, Newland AC. α-2a recombinant Interferon in HIV associated thrombocytopenia. Br Med J 1987; 295:1519.
120. Garavelli PL. Treatment of HIV-associated thrombocytopenia. Hematologica 1989; 74:412.
121. Lever AML, Brook MG, Yap I, Thomas HC. Treatment of thrombocytopenia with α-interferon. Br Med J 1987; 295:1519-20.
122. Marroni M, Gresele P, Landonio G, Lazzarin A, Coen M, Vezza R, et al. Interferon-α is effective in the treatment of HIV-related, severe, zidovudine-resistant thrombocytopenia. Ann Intern Med 1994; 121:423-429.
123. Northfelt DW, Kaplan LD, Abrams DI. Continuous, low-dose therapy with interferon-α for human immunodeficiency virus (HIV)- related immune thrombocytopenia. AM J Hematol 1994; 38:238-9.
124. Morrison AS, Steigbigel RT. Human immunodeficiency virus infection (acquired immunodeficiency syndrome, AIDS). En: Beutler E, Lichtman NA, Coller BS, Kipps TJ, editors. Williams Hematology. New York: McGraw-Hill, 1995; 975-97.
125. Schacter LP, Rozencweig M, Beltangady M, Allan JD, Canetta R, Cooley TP, et al. Effects of therapy with didanosine on hematologic parameters in patients with advanced human immunodeficiency virus disease. Blood 1992; 80:2969-76.
126. Kahn JO, Lagakos SW, Richmnan DD, Cross A, Pettinelli C, Liou S, et al. A controlled trial comparing continued zidovudine with didanosine in human immunodeficiency virus infection. N Engl J Med 1992; 327:581-7.
127. Needleman SW, Sorace J, Poussin-Rosillo H. Low-dose splenic irradiation in the treatment of autoimmune thrombocytopenia in HIV-infected patients. Ann Intern Med 1992; 116:310-1.
128. Mittelman A, Bertram J, Henry DH, Snyder HW, Messersmidt GL, Viavarella D, et al. Treatment of patients with HIV thrombocytopenia and hemolytic uremic syndrome with protein A (Prosorba column) immunoadsorption. Semin Hematol 1989; 26 (Suppl 1): 15-8.
129. Scolaro M, Kennedy P. Lack of efficacy of on-line protein A adsorption in treatment of HIV-associated ITP. V International Conference on AIDS 1989; 56.
130. Soubrane C, Tourani JM, Anoriev JM, Visonneau S, Beldjard K, Israel-Biet D, et al. Biologic response to anti-CD16 monoclonal antibody therapy in a human immunodeficiency virus-related thrombocytopenic purpura patient. Blood 1993; 81:15-9
131. Bloom EJ, Abrams DI, Rodgers GM. Lupus anticoagulant in the acquired immunodeficiency syndrome. JAMA 1986; 256:491-3.
132. Cohen AJ, Philips TM, Kessler CM. Circulating coagulation inhibitors in the acquired immunodeficiency syndrome. Ann Intern Med 1986; 104:175-80.
133. Berstein L, Cappacino A, Cappacino H. Platelet function and bound antibodies in AIDS-ARC patients with thrombocytopenia. Blood 1987; 70: 118a.
134. Stahl CP, Wideman CS, Spira TJ, Haff EC, Hixon GJ, Evatt BL. Protein S deficiency in men with long-term human immunodeficiency virus infection. Blood 1993; 81:1801-7.
135. McNeil HP, Chesterman CN, Krilis SA. Immunology and clinical importance of antiphospholipd antibodies. Adv Immunol 1991;49:193-280.
136. Bevers EM, Galli M, Barbui T, Comfurius P, Zwaal RFA. Lupus anticoagulants IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin. Thromb Haemost 1991; 66:629-32.
137. Galli M, Confurius P, Barbui T, Zwaal RFA, Bevers EM. Anticoagulant activity of β2-glycoprotein I is potentiated by a disctinct subgroup of anticardiolipin antibodies. Thromb Haemost 1992; 68:297-300.
138. Gold JE, Haubenstock A, Zalusky R. Lupus anticoagulant in AIDS. N Engl J Med 1986; 314:1252-3.
139. LeFrere JJ, Gozin D, Modai J, Vittecoq D. Circulating anticoagulant in the acquired immunodeficiency syndrome. Ann Intern Med 1987; 107:429-30.
140. Asherson RA, Khamashta MA, Ordi-Ros J, Derksen RHWM, Machin SJ, Barquinero J, et al. The "primary" antiphospholipid syndrome: major clinical and serologic features. Medicine 1989; 68:366-74.
141. Cohen H, Mackie IJ, Anagnostopoulus N, Savage GF, Machin SJ. Lupus anticoagulant, anticardiolipin antibodies, and human immunodeficiency virus in hemophilia. J Clin Pathol 1989; 42:629-33.
142. Brien W, Inwood M, Denome G. Antiphospholipid antibodies in haemophiliacs. Br J Haematol 1987; 66:270-1.
143. Taillan B, Roul C, Fuzibet JG, Vinti H, Psce A, Bayle J, et al. A prospective study of circulating anticoagulants in 157 human immunodeficiency virus (HIV) seropositive patients. Annales Interne 1989; 140:405-7.
144. Mulhall BP, Naselli G, Whittingham S. Anticardiolipin antibodies in homosexual men: prevalence and lack of association with immunodeficiency virus (HIV) infection. J Clin Immunol 1989; 9:208-13.
145. Intrator L, Oksenhendler E, Desforges L, Bierling P. Anticardiolipin antibodies in HIV infected patient with or without immune thrombocytopenia. Br J Haematol 1987; 66:269-70.
146. Nilsson TK, Lofvenberg E. Decreased fibrinolytic capacity and increased von Willebrand factor levels as indicators of endothelial cell dysfunction in patients with lupus anticoagulant. Clin Rheumatol 1989; 8:58-63.
147. Tsakiris DA, Marbet GA, Makris PE, Settas L, Duckert F. Impaired fibrinolysis as an essential contribution to thombosis in patients with lupus anticoagulant. Thromb Haemost 1989; 61:175-7.
148. Stimler MM; Quismorio FP, McGehee WG, Boylen T, Sharma OP. Anticardiolipin antibodies in acquired immunodeficiency syndrome. Arch Intern Med 1989; 149:1833-5.
149. Canoso RT, Zon LI, Groopman JE. Anticardiolipin antibodies associated with HTLV-III infection. Br J Haematol 1987; 65:495-8.
150. Smith KJ, Skelton HG, James WD, Angritt P, Scherbenske J, Vaughan K, et al. Cutaneous histopathologic findings in "antiphospholipid syndrome";. Correlation wih disease, including human immunodeficiency virus disease. Arch Dermatol 1990; 126:1176-83.
151. De Prost D, Katlama C, Pialoux G, Karsenty-Mathonnet F. Heparin-like anticoagulant associated with AIDS. Thromb Haemost 1987; 57:239.
152. Palmer RN, Rick ME, Rick PD, Zeller JA, Gralnick HR. Circulant heparan sulfate anticoagulant in a patient with a fatal bleeding disorder. N Engl J Med 1984, 310:1696-9.
153. Chapman GS, George CB, Danley DB. Heparin-like anticoagulant associated with plasma cell myeloma. Am J Clin Pathol 1985; 83:764-6.
154. Yospur LS, Sun NCJ, Figueroa P, Niihara Y. Concurrent thrombotic trhombocytopenic purpura and immune thrombocytopenic purpura in an HIV-positive patient: case report and review of the literature. Am J Hematol 1996; 50:73-8.
155. Boccia RV, Gelmann EP, Baker CC, Marti G, Longo DL. A hemolytic uremic syndrome with acquired immunodeficiency syndrome. Ann Intern Med 1984; 101:716-7.
156. Ucar A, Fernandez HF, Byrnes JJ, Lian ECY, Harrington J. Thrombotic microangiopathy and retroviral infections: a 13-year experiencie. Am J Hematol 1994; 54:304-9.
157. Leaf AN, Laubenstein LJ, Raphael B. Hoechster H. Baez L, Karpatkin S. Thrombotic thrombocytopenic purpura associated with human immunodeficiency virus type 1 (HIV-1) infection. Ann Intern Med 1988; 109:194-7.
158. Eisenstaedt RC, Colman RW, Marder VJ. Thrombotic thrombocytopenic purpura. En: Colman RW, Hirsh J. Marder VJ, Salzman EW, editors. Hemostasis and thrombosis. Philadelphia: JB Lippincott, 1995:1016-25.
159. Schmidt JL. Thrombotic thrombocytopenic purpura: successful treatment unlocks etiologic secrets. Mayo Clin Proc 1989; 64:956-61.
160. Botti AC, Hyde P. DiPillo F. Thrombotic thrombocytopenic purpura in a patient who subsequently developed the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1988; 109:242-3.
161. Meisenberg BR, Robinson WL, Mosley CA, Duke MS, Rabetoy GM, Kosty MP. Thrombotic thrombocytopenic purpura in human immunodeficiency virus (HIV)-seropositive males. Am J Hematol 1988; 27:212-5.
162. Nair JGM, Bellevue R. Bertoni M, Dosik H. Thrombotic thrombocytopenic purpura in patients with the acquired immunodeficiency syndrome (AIDS) related complex: a report of two cases. Ann Intern Med 1988;109:209-12.
163. Cleary TG. Escherichia coli that cause hemolytic uremic syndrome. Infect Dis Clin North Am 1992; 6:163-76.
164. Lichtin AE, Schreiber AD, Hurwitz S. Willoughby L, Silberstein L Efficacy of intensive plasmapheresis in thrombotic thrombocytopenic purpura. Arch Intern Med 1987; 147:2122-6.
165. Shepard KV, Bukowsky RM. The treatment of thrombotic thrombocytopenic purpura with exchange transfusions, plasma infusions, and plasma exchange. Semin Hematol 1987; 24:178-93.